By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actavis 

Morris Corporate Center III
400 Interpace Parkway
Parippany  New Jersey  07054  U.S.A.
Phone: 1-862-261-7000 Fax: n/a


SEARCH JOBS

Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland.

Actavis is the world’s third-largest generics prescription drug manufacturer, with more than 750 products marketed globally through operations in more than 60 countries. Actavis’ global branded pharmaceutical business develops and markets products principally in Urology and Women’s Health, and is committed to developing and marketing biosimilars products in Women’s Health, Oncology and other therapeutic categories. In addition, Actavis is the fourth-largest U.S. generic pharmaceutical product distributor through its Anda, Inc. business, and also develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.

"Twice As" Video

"Our Winning Way" Video


Key Statistics


Email: actavis@actavis.com
Ownership: Public

Web Site: Actavis
Employees:
Symbol: ACT
 



Industry
Pharmaceutical






Company News
Medicines360 And Actavis (ACT) Announce FDA Acceptance For Filing Of NDA For Levosert™ IUD 7/21/2014 12:07:21 PM
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014 9:00:59 AM
Actavis (ACT) Execs Bag As Much As $186 Million In Merger Success Awards 7/9/2014 11:01:06 AM
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014 2:19:36 PM
IMPAX Laboratories, Inc. (IPXL) Acquires Two Products From Actavis (ACT) 7/3/2014 6:17:54 AM
Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger 7/2/2014 10:16:09 AM
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014 8:33:26 AM
Actavis (ACT) Completes Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014 10:31:10 AM
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Forest 7/1/2014 10:15:29 AM
Actavis (ACT) To Host Second Quarter 2014 Earnings Conference Call And Webcast 6/30/2014 10:01:21 AM
12345678910...
//-->